Quantum Surgical Raises Series A Capital from Ally Bridge
publication date: Jun 5, 2018
Quantum Surgical, a French company building new minimally invasive surgical tools for cancer, completed an initial investment from Ally Bridge Group, a China-centered healthcare investor. Quantum said the investment is the first part of a $50 million Series A round. The company is developing a robotic platform to improve physicians' ability to assess, plan and treat a broad spectrum of medical conditions, especially early-stage cancer. Lifetech Scientific, a China medical device company, also participated in the investment through its JV with ABG and will collaborate with Quantum Surgical in the China market. More details....
Stock Symbol: (HK: 1302)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.